What is Hormone Replacement Therapy (HRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hormone Replacement Therapy (HRT) should be used with caution and only for the management of menopausal symptoms, as the risks of HRT may outweigh the benefits for chronic disease prevention, as noted in the most recent and highest quality study 1.

Key Considerations

  • HRT may be considered for women experiencing severe menopausal symptoms, but should be used at the lowest effective dose for the shortest possible time, as recommended by 1.
  • The decision to initiate or continue HRT should be made on the basis of discussions between a woman and her clinician, taking into account individual risk factors and preferences, as suggested by 1.
  • Women should be informed of the potential risks of HRT, including venous thromboembolism, coronary heart disease, and stroke, as well as the potential benefits, such as relief of menopausal symptoms and improved bone health, as noted in 1.

HRT Regimens

  • A typical regimen includes estrogen (such as estradiol 0.5-1mg daily orally, or 0.025-0.05mg/day via patch) combined with progesterone (such as micronized progesterone 100-200mg daily) for women with an intact uterus to protect against endometrial cancer, as recommended by 1.
  • Women who have had a hysterectomy can take estrogen alone, as suggested by 1.

Monitoring and Follow-up

  • Women taking HRT should be monitored regularly for potential side effects and risks, and the decision to continue HRT should be re-evaluated annually, as recommended by 1.
  • Alternative treatments for menopausal symptoms and chronic disease prevention should be discussed with women who are not candidates for HRT or who prefer not to take HRT, as noted in 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Definition and Purpose of HRT

  • Hormone Replacement Therapy (HRT) is considered the gold standard for managing vasomotor and vaginal symptoms of menopause 2.
  • HRT is used to alleviate symptoms such as hot flashes, diaphoresis, vaginal atrophy, and dryness, which can impact a woman's quality of life 2.

Types and Administration of HRT

  • HRT can be administered in various forms, including injections and transdermal formulations 2.
  • Estrogen can be combined with progestin or bazedoxifene (a selective estrogen receptor modulator - SERM) to minimize malignancy risk in women with an intact uterus 2.
  • Continuous daily oral micronized estradiol and progesterone can be used as a combination therapy for menopausal women 3.
  • Different dosages and combinations of estrogen and progestin can be used, such as estradiol valerate (E2V) and medroxyprogesterone acetate (MPA) 4.

Benefits and Risks of HRT

  • HRT has been shown to be effective in improving symptoms, minimizing side effects, and improving lipid profiles in menopausal women 3.
  • However, HRT carries significant risks, including stroke, cardiovascular disease, breast cancer, and venous thromboembolism 2.
  • The risks and benefits of HRT can vary depending on the type and dosage of hormones used, as well as individual patient factors 5.
  • Some studies suggest that HRT with estradiol and progesterone may have a better safety profile compared to other estrogens and progestins 5.

Effects of HRT on Breast Tissue

  • HRT with estrogen or estrogen plus medroxyprogesterone acetate has been associated with increased epithelial proliferation in the normal postmenopausal breast 6.
  • This increased proliferation may be related to an increased risk of breast cancer, although further studies are needed to confirm this association 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2000

Research

Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.